Food Supplement for Restoring Male Sex Drive (Libido)

Abstract

A food supplement for restoring male sex drive (libido) comprises in a daily dose a set of L-arginine, rutin from pollen or beebread, decenic acids from drone brood, zinc from a zinc compound, and vitamin B6. It also comprises icariin from horny goat weed, saponins from true or false ginseng root, and ecdysteroids from Leuzea or crowned saw-wort, in various combinations thereof.

Description

CROSS-REFERENCE TO RELATED APPLICATIONS[0001]The present application is a continuation-in-part of U.S. application Ser. No. 14 / 422,206 filed Feb. 18, 2015, pending, which is a U.S. National phase application of International application WO 2014 / 031026 filed Mar. 06, 2013 and claiming priority from Russian application 2012135560 filed Aug. 20, 2012, all three above applications being incorporated for reference into the present application in their entirety.BACKGROUND OF THE INVENTION1. Field of the Invention[0002]The invention relates to biologically active food supplements to restore sex drive (libido) and improve sexual function in male and is based on natural ingredients.2. Description of Related Art[0003]Sexual dysfunction, including decreased libido, erectile and ejaculation dysfunction, as well as infertility, are widespread medical, psychological, and social problems.[0004]Today, there exists quite a few pharmaceutical drugs—inhibitors of phosphodiesterase of type 5 (PDEI-5), ...

AI Technical Summary

Benefits of technology

The patent is about a new invention of a natural food supplement that can restore sexual drive and improve sexual function in men. The supplement is made from natural ingredients and is designed to address common medical and social issues related to sexual dysfunctions. The invention is based on the use of antibodies to human endothelial NO-synthase, which is a key enzyme involved in the production of nitric oxide and the relaxation of smooth muscles in the penis. The supplement has been tested in animals and has shown promising results in improving sexual function. The invention aims to provide a safer and more effective alternative to existing pharmaceutical drugs and to address the limitations of current androgen replacement therapy.

Problems solved by technology

Sexual dysfunction, including decreased libido, erectile and ejaculation dysfunction, as well as infertility, are widespread medical, psychological, and social problems.

At the same time, the high cost of these drugs and significant risk of adverse drug reactions, especially in patients with cardiovascular disease, limit their widespread use.

In addition, there are patients (15-42%) in which PDEI-5 are inefficient due to the mechanism of action of this group of drugs.

As far as androgen replacement therapy (ART) employing testosterone preparations used per os, intramuscularly, or percutaneously) is concerned, there left a number of unresolved problems despite the variety of dosage forms.

Firstly, none of the drugs is able to precisely reproduce a circadian rhythm in the serum testosterone level.

Secondly, a number of studies have shown that exogenous increase of testosterone has a greater influence on the erectile function rather than on sexual-erotic, libidinal component, this being caused by a visceral defect of hypothalamic brain structures.

Thirdly, androgens are potentially able to have adverse effects not only due to cutting off its own mechanisms of androgen production but also due to affecting homeostasis maintaining systems suppressing the production of endogenous androsteroids.

Another disadvantage of this composition is the use of a medicinal plant Tribulus terrestris, which is prohibited by Rospotrebnadzor (a Russian analog of the FDA) for using as a raw material for the production of biologically active additives to food because of the high toxicity of this plant.